Wen Song

1.0k citations
34 papers · 500 indexed · h-index 11
Topics
Cancer-related molecular mechanisms research (6 papers)MicroRNA in disease regulation (4 papers)Ferroptosis and cancer prognosis (4 papers)

In The Last Decade

Wen Song

33 papers receiving 492 citations

Peers

Wen Song
Comparison fields: 5 of 80
  • Molecular Biology 226
  • Cancer Research 147
  • Biomedical Engineering 108
  • Pulmonary and Respiratory Medicine 96
  • Biomaterials 88
Replace Yaping Wu with:
Yaping Wu China
Lingjie Fu China
Saeideh Jafarinejad‐Farsangi Iran
Weilin Sang China
Yipu Zhao China
Shima Gholizadeh Netherlands
Kerong Wu China
Zhouliang Wu China
Chunlei Dai China
Xisheng Wang China
Wen Song relative to Yaping Wu China Yaping Wu's profile →
Citations per field
00.5×5.5×
Yaping Wu · 1×
Citations per year

Countries citing papers authored by Wen Song

Since Specialization
Citations

This map shows the geographic impact of Wen Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Song more than expected).

Fields of papers citing papers by Wen Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Song. The network helps show where Wen Song may publish in the future.

Co-authorship network of co-authors of Wen Song

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Song. A scholar is included among the top collaborators of Wen Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Song. Wen Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 4
4 4
5 8
6 6
7 4
8 26
9 7
10 9
11 10
12 5
13 1
14 12
15 21
16 25
17 104
18
[A correlation study between diarrhea-predominant irritable bowel syndrome complicated functional dyspepsia patients of Gan-stagnation Pi-deficiency syndrome and gastrointestinal hormones].
2
19 67
20
[Study on omeprazole 20 mg twice weekly in prevention of duodenal ulcer relapse].
1

About Wen Song

Wen Song is a scholar working on Cancer Research, Urology and Gastroenterology, having authored 34 papers that have together received 500 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (4 papers). The work is most often cited by research in Cancer Research (147 citations), Biomaterials (88 citations) and Molecular Biology (226 citations). Wen Song has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Tao Wang, Ning Gu, Ke Chen, Shaohua Xu, Caiyun Yan, Lina Song, Yu Zhang, Fengchao Zang, Gong Chen and Jun Xie. Their work appears in journals such as PLoS ONE, Biomaterials and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026